| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |